معرفی
Dr. Eduard Shantsila serves as Head of the Department of Primary Care and Mental Health and Senior Clinical Lecturer at the University of Liverpool's Medical School. He concurrently practices as a General Practitioner at Brownlow Health GP Partnership and as a GP with Specialist Interest in Hypertension at Liverpool Heart and Chest Hospital, integrating clinical cardiology expertise with primary care since joining the university in August 2021 after completing GP training in 2020.
His research focuses on holistic cardiovascular care for disadvantaged populations, frailty, and mental health comorbidities, with specialization in hypertension management and digital health applications. Current work emphasizes cardiovascular health (hypertension, atrial fibrillation, heart failure) within medical complexity, multimorbidity, and polypharmacy frameworks through multidisciplinary collaborations bridging primary and secondary care.
His 2025 publications reveal strong trends in machine learning for hypertension outcomes prediction, cost-effectiveness modeling of cholesterol treatments, immunological mechanisms in cardiovascular disease (particularly monocyte subsets), and body composition interactions with cardiovascular parameters. Methodologically, his work leverages registry data, randomized trials like IMPRESS-AF, and systematic reviews to address real-world clinical challenges in community settings.
Scientific recognition includes:
- 2018 BMA Medical Book Award (Highly Commended) for cardiology section in 'Textbook of Occupational Medicine Practice'
- 2016 CRN West Midlands Clinical Research Impact Award with SWBH Atrial Fibrillation Research Team
- 2016 Sandwell and West Birmingham Hospitals Star Award for Research Excellence
- 2008 Heart Failure Association Research Fellowship (ESC)
- 2006 Clinical Training Fellowship (ESC)
As an active PhD supervisor with 7 current and 7 completed students, he leads significant grant-funded initiatives including NIHR RfPB (£499,999, PI) for telehealth solutions, NIHR/OLS (£10.5M, Co-I) for mental health innovation, and NIHR-AIM (£2.8M, Co-I) for AI-driven multimorbidity care. His grant portfolio demonstrates sustained success in securing major funding for cardiovascular-primary care integration.
He leads an internationally recognized monocyte research group that has mentored seven UK cardiology trainees to MD/PhD completion and remains actively involved in the E-ECHOES Study and IMPRESS-AF trial, driving translational cardiovascular research within community healthcare contexts.
